Low metabolic activity in primary gastric adenocarcinoma is associated with resistance to chemoradiation and the presence of signet ring cells
- 13 May 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Surgery Today
- Vol. 50 (10), 1223-1231
- https://doi.org/10.1007/s00595-020-02018-2
Abstract
Purposes Preoperative chemoradiation is a potential treatment option for localized gastric adenocarcinoma (GAC). Currently, the response to chemoradiation cannot be predicted. We analyzed the pretreatment maximum standardized uptake value (SUVmax) and total lesion glycolysis (TLG) on positron emission tomography/computed tomography as potential predictors of the response to chemoradiation. Methods We analyzed the SUVmax and TLG data from 59 GAC patients who received preoperative chemoradiation. We used logistic regression models to predict a pathologic complete response (pCR) and Kaplan-Meier curves to determine overall survival among patients with high and low SUVmax or TLG. Results Twenty-nine patients (49%) had Siewert type III adenocarcinoma and 30 (51%) had tumors located in the lower stomach. Forty-one patients had poorly differentiated GAC, and 26 had signet ring cells. The median SUVmax was 7.3 (0-28.2) and the median TLG was 56.6 (0-1881.5). Patients with signet ring cells had a low pCR rate, as well as a low SUVmax and TLG. In the multivariable logistic regression model, high SUVmax was a predictor of pCR (odds ratio = 11.1, 95% confidence interval = 2.12-50.0, p = 0.004). Overall survival was not associated with the SUVmax (log-rank p = 0.69) or TLG (log-rank p = 0.85) Conclusion A high SUVmax was associated with sensitivity to chemoradiation and pCR in GAC, and signet ring cells seemed to confer resistance.Funding Information
- U.S. Department of Defense (CA150334 and CA162445)
- National Cancer Institute (CA129906, CA127672, CA138671, and CA172741)
This publication has 39 references indexed in Scilit:
- Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2011
- Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expressionNuclear Medicine Communications, 2010
- High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2010
- Early Metabolic Response Evaluation by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography Allows In vivo Testing of Chemosensitivity in Gastric Cancer: Long-term Results of a Prospective StudyClinical Cancer Research, 2008
- The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximabGastric Cancer, 2007
- Phase II Trial of Preoperative Chemoradiation in Patients With Localized Gastric Adenocarcinoma (RTOG 9904): Quality of Combined Modality Therapy and Pathologic ResponseJournal of Clinical Oncology, 2006
- Preoperative Chemo-Radiation-Induced Ulceration in Patients with Esophageal Cancer: A Confounding Factor in Tumor Response Assessment in Integrated Computed Tomographic-Positron Emission Tomographic ImagingJournal of Thoracic Oncology, 2006
- Paclitaxel-Based Chemoradiotherapy in Localized Gastric Carcinoma: Degree of Pathologic Response and Not Clinical Parameters Dictated Patient OutcomeJournal of Clinical Oncology, 2005
- Multi-Institutional Trial of Preoperative Chemoradiotherapy in Patients With Potentially Resectable Gastric CarcinomaJournal of Clinical Oncology, 2004
- Detection of response to chemotherapy using positron emission tomography in patients with oesophageal and gastric cancerBritish Journal of Surgery, 1998